Loading stock data...

Elixir Capital Limited

BSE: ELIXIR

BSE
101.75 -4.10 (-3.87%)

Prev Close

105.85

Open Price

103.05

Volume

1,736

Today Low / High

100.25 / 106.95

52 WK Low / High

91.85 / 146

Range

97 - 107

The stock is currently available for trading on the Bombay Stock Exchange (BSE). Its price is 101.75, reflecting a change of -4.1 (-3.87341%). The expected target range on the BSE is 97 - 107. The stock is showing a downward trend on the BSE. This could indicate a potential risk for investors who are considering buying at this moment.

20 Feb 107.60 0.37%
19 Feb 110.00 -2.14%
18 Feb 110.00 -3.77%
17 Feb 109.30 -3.48%
16 Feb 109.00 0.60%
13 Feb 105.50 3.41%
12 Feb 105.85 -1.65%
11 Feb 108.00 -1.99%
10 Feb 110.00 -2.95%
09 Feb 105.00 0.71%
06 Feb 110.00 -1.09%
05 Feb 110.00 -0.64%
04 Feb 105.70 1.04%
03 Feb 108.00 -1.20%
02 Feb 106.00 -0.52%
01 Feb 108.95 -3.58%
30 Jan 111.00 -3.98%
29 Jan 112.00 -1.36%
28 Jan 103.00 9.44%

Elixir Capital Limited Graph

Elixir Capital Limited Price Target Predictions: Bullish vs. Bearish Scenarios with Ranges

If you are looking for the target price for Elixir Capital Limited T1, T2, T3 for both Bullish and Bearish scenarios, here it is. For Bullish: T1, T2, T3. For Bearish: T1, T2, T3. The stock current price is 101.75, with potential price targets ranging from T1, T2, and T3 in both directions based on market conditions.

Scenario Price Target Range
Bullish Scenario 101.75 102.77 92.49 - 113.04
103.79 83.03 - 124.54
104.80 73.36 - 136.24
Bearish Scenario 101.75 100.73 90.66 - 110.81
99.72 79.77 - 119.66
98.70 69.09 - 128.31

Overview of Elixir Capital Limited

ISIN

INE785D01012

Industry

Investment - Banking & Investment Services

Vol.Avg

1,701

Market Cap

626,745,600

Last Dividend

1.25

Official Website

Visit Website

IPO Date

2024-12-30

DCF Diff

-220.72

DCF

333

Financial Ratios Every Investor Needs

Stock Dividend of ELIXIR

Date Label Adj Dividend Dividend Record Date Payment Date Declaration Date
2025-08-19 August 19, 25 1.25 1.25 2025-08-19 2025-09-25
2024-08-16 August 16, 24 1.25 1.25 2024-08-17 2024-09-25
2023-08-18 August 18, 23 1.25 1.25 2023-08-19 2023-09-25
2022-08-18 August 18, 22 1.25 1.25 2022-08-18 2022-09-23
2021-08-17 August 17, 21 1.25 1.25 2021-08-18 2021-09-24

Stock Rating Details for ELIXIR

Metric Value Recommendation
Overall Rating C+ Sell
DCF Score 5 Strong Buy
ROE Score 1 Strong Sell
ROA Score 1 Strong Sell
Debt-to-Equity (DE) Score 2 Sell
Price-to-Earnings (PE) Score 1 Strong Sell
Price-to-Book (PB) Score 3 Neutral

Annual Financial Income Report

Date Revenue Co.Rev GP GPR R&D Expenses G&A Expenses Operating Income Net Income EPS EBITDA NIR
2025-03-31 34.81 Cr 12.17 Cr 22.64 Cr 0.6503 0.00 Cr 0.60 Cr 19.54 Cr 9.33 Cr 16.04 20.55 Cr 0.2679
2024-03-31 34.53 Cr 3.45 Cr 31.08 Cr 0.9002 0.07 Cr 0.66 Cr 27.04 Cr 15.61 Cr 26.89 27.67 Cr 0.4520
2023-03-31 3.17 Cr 2.39 Cr 1.66 Cr 0.5250 0.01 Cr 0.76 Cr -0.61 Cr -2.44 Cr -4.20 -1.30 Cr -0.7693
2022-03-31 22.95 Cr 2.30 Cr 21.89 Cr 0.9539 0.01 Cr 0.65 Cr 19.24 Cr 9.60 Cr 16.54 18.96 Cr 0.4182
2021-03-31 18.63 Cr 1.82 Cr 17.62 Cr 0.9457 0.01 Cr 0.66 Cr 15.49 Cr 9.12 Cr 15.72 14.93 Cr 0.4896

Annual Financials Balance Sheet

Date C&C Equ. Tot. Assets Tot. Liab. Stock. Equity Tot. Debt Net Debt Inv. PP&E (Net) Curr. Def. Rev. Non-Curr. Def. Rev. LT Invest. Curr. Liab.
2025-03-31 10.88 Cr 115.58 Cr 35.71 Cr 56.7731 Cr 31.32 Cr 20.45 Cr 59.00 Cr 1.82 Cr 0.00 Cr 0.00 Cr 0.00 Cr 35.3983 Cr
2024-03-31 9.59 Cr 96.38 Cr 28.17 Cr 48.4341 Cr 23.60 Cr 14.01 Cr 54.42 Cr 1.80 Cr 0.00 Cr 0.00 Cr 22.17 Cr 28.1379 Cr
2023-03-31 11.07 Cr 67.53 Cr 19.29 Cr 33.8155 Cr 7.34 Cr -3.73 Cr 30.92 Cr 2.06 Cr 7.39 Cr 0.00 Cr -2.32 Cr 19.2563 Cr
2022-03-31 15.89 Cr 82.64 Cr 29.98 Cr 37.2398 Cr 17.68 Cr 1.79 Cr 40.62 Cr 2.22 Cr 7.42 Cr 0.00 Cr -3.28 Cr 29.9460 Cr
2021-03-31 13.31 Cr 72.83 Cr 32.17 Cr 28.6312 Cr 17.44 Cr 4.13 Cr 35.05 Cr 2.43 Cr 0.00 Cr 0.00 Cr -7.64 Cr 32.1038 Cr

Annual Financials Cash Flow Statement

Date Operating Cash Investing Cash Financing Cash Free Cash Cash Change Cash at End CapEx Income Debt Repay Dividends Inventory
2025-03-31 2.0033 Cr -5.4156 Cr 4.7015 Cr 1.1302 Cr 1.2892 Cr 10.8757 Cr -0.8731 Cr 18.0221 Cr 7.7232 Cr -0.9878 Cr -4.5817 Cr
2024-03-31 -17.0208 Cr 1.7893 Cr 13.7459 Cr -17.0208 Cr -1.4856 Cr 9.5865 Cr 0.0000 Cr 15.6064 Cr 16.2557 Cr -0.9878 Cr -23.4985 Cr
2023-03-31 5.9601 Cr 1.6771 Cr -12.4572 Cr 5.7758 Cr -4.8200 Cr 11.0720 Cr -0.1844 Cr -2.6643 Cr -10.3376 Cr -0.9878 Cr 9.7063 Cr
2022-03-31 4.5817 Cr 0.4147 Cr -2.4116 Cr 4.4567 Cr 2.5847 Cr 15.8920 Cr -0.1249 Cr 17.0049 Cr -0.0318 Cr -0.9878 Cr -5.5755 Cr
2021-03-31 -2.0208 Cr -3.3508 Cr 14.2427 Cr -2.1661 Cr 8.8712 Cr 13.3073 Cr -0.1453 Cr 13.6665 Cr 16.2026 Cr -1.0091 Cr -26.9195 Cr

Quarterly Financial Income Report

Date Revenue Co.Rev GP GPR Operating Income Net Income EPS EBITDA NIR
2025-09-30 10.86 Cr 4.91 Cr 5.95 Cr 0.5477 4.35 Cr 1.71 Cr 2.94 4.56 Cr 0.1573
2025-06-30 10.81 Cr 5.41 Cr 5.39 Cr 0.4991 4.14 Cr 2.73 Cr 4.70 5.42 Cr 0.2522
2025-03-31 -4.05 Cr 4.79 Cr -8.84 Cr 2.1830 -9.81 Cr -6.27 Cr -10.78 -9.68 Cr 1.5480
2024-12-31 5.96 Cr 2.74 Cr 3.22 Cr 0.5401 2.26 Cr 0.88 Cr 1.52 2.56 Cr 0.1482
2024-09-30 18.16 Cr 2.23 Cr 16.02 Cr 0.8824 15.88 Cr 8.36 Cr 14.41 15.73 Cr 0.4605

Quarterly Financials Balance Sheet

Date Cash & Equiv. Short-Term Inv. Cash & Short-Term Net Receivables Inventory Total Curr. Assets PP&E (Net) Total Assets Total Liabilities
2025-09-30 3.89 Cr 8.54 Cr 12.43 Cr 12.92 Cr 70.65 Cr 96.41 Cr 1.74 Cr 128.04 Cr 43.16 Cr
2025-06-30 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr -79.87 Cr
2025-03-31 10.88 Cr 0.03 Cr 10.91 Cr 13.37 Cr 59.00 Cr 83.91 Cr 1.82 Cr 115.58 Cr 35.71 Cr
2024-12-31 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr -87.12 Cr
2024-09-30 8.07 Cr 0.04 Cr 8.11 Cr 10.94 Cr 76.74 Cr 96.12 Cr 1.93 Cr 121.53 Cr 34.41 Cr

Quarterly Financials Cash Flow Statement

Date Net Income Operating Cash Flow Investing Cash Flow Financing Cash Flow Net Cash Change Cash at End Cash at Beginning CapEx Free Cash Flow
2025-06-30 2.73 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2025-03-31 -6.27 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2024-12-31 0.88 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2024-09-30 8.36 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2024-06-30 6.35 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr

Splits History

Date Label Split Ratio
No split history data available.

Similar Stocks: Investment - Banking & Investment Services

Company Name Symbol Price Market Cap Volume
Medi Assist Health Ser L MEDIASSIST ₹388.60 ₹28,934,277,764.00 ₹100,513.00

Key Executives

Chief Financial Officer
Varun Mehta

Gender: male

Year Born:

Company Secretary & Compliance Officer
Hetal Mody

Gender: female

Year Born:

FAQs about Elixir Capital Limited

Who is the CEO of the company?

The CEO is Hetal Mody.

What is the current market price of the stock?

The current price is ₹108.00.

What is the 52-week price range?

The range is ₹91.85-164.35.

What is the market capitalization of the company?

The market capitalization is ₹62.67 crores.

What is the dividend yield?

The dividend yield is 1.16%.

What is the Price-to-Earnings (P/E) ratio?

The P/E ratio is -65.92.

Which sector does the company belong to?

The company operates in the Financial Services sector.

What does the company do?

Overview of Elixir Capital Limited (ISIN: INE785D01012) is a leading Investment - Banking & Investment Services in India. With a market capitalization of ₹62.67 crores and an average daily volume of 1,701 shares, it operates in the Investment - Banking & Investment Services. The company last declared a dividend of ₹1.25.